ClinicalTrials.govpublic full text
SGLT2 Inhibitors and Reducing the Risk of Cancers Among Diabetics , an Observational Study
cancer, diabetes mellitus, type 2, interleukin 6, sglt2 inhibitors
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 353427
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.